MREO today
$0.31+$0.01 (+2.92%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bullish
Daily trend turns down below $0.24
Key levels
Resistance$0.35
Resistance$0.32
Support$0.27
Support$0.24
Latest news & SEC filings
EarningsMereo BioPharma Posts Q3 2026 Financials
AnalystBTIG kept its Buy rating on Mereo BioPharma (MREO).
EarningsMereo BioPharma Group reports Q3 EPS of $(0.01), sales of $800,000
SEC FilingMereo BioPharma Group plc filed a report on a major company event (Form 8-K)
All MREO news →About Mereo BioPharma
Mereo BioPharma is a clinical-stage biopharmaceutical company that develops therapies for rare diseases. Its lead product candidates include setrusumab for osteogenesis imperfecta and alvelestat for alpha-1 antitrypsin deficiency lung disease. The company conducts clinical trials in North America and Europe and works with contract research organizations and third-party manufacturers.
Based on the company's 10-K filed Mar 19, 2026.
Nasdaq · Healthcare
Mereo BioPharma Group plc (MREO)
What Is the Price Target for MREO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is MREO a Buy or Sell Right Now?
Thesis
- •Revenue growing -95.0% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MREO.
Start Free Trial →Is MREO Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
12
Moat Score
NONE
4/9
Piotroski Score
9.7
Altman Z-Score
What Is Smart Money Doing with MREO?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MREO Growth Story
Revenue YoY
-95.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
16.67%
FCF Growth YoY
5.6%
Revenue Trend
DECLINING
Dark Pool Trades for MREO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MREO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:59:34 | $0.30 | 2,298 | $$687 | SELL |
| 22:11:33 | $0.30 | 1,200 | $$358 | SELL |
| 20:31:39 | $0.31 | 3,900 | $$1K | BUY |
| 19:55:57 | $0.30 | 1,614 | $$492 | SELL |
| 19:49:58 | $0.30 | 1,800 | $$545 | SELL |
5 dark pool trades shown · $$3K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Mereo BioPharma Group plc (MREO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MREO — frequently asked questions
What is MREO stock price today?
Mereo BioPharma Group plc (MREO) is at $0.31, up 2.92% (+$0.01) at the Nov 11, 2026 close.
Why is MREO stock moving today?
Latest MREO news — Nov 10, 2026: Mereo BioPharma Posts Q3 2026 Financials · Nov 10, 2026: BTIG kept its Buy rating on Mereo BioPharma (MREO).
What do analysts rate MREO?
Analyst ratings for MREO: 0 Buy, 0 Hold, 1 Sell — consensus Sell.
Did MREO beat earnings?
MREO last reported on Aug 11, 2026: EPS -$0.01 vs -$0.01 expected — in line.
Does MREO pay a dividend?
MREO does not currently pay a dividend.
What are MREO support and resistance levels?
Support: $0.27, $0.24, $0.20. Resistance: $0.32, $0.35, $0.39.
What are insiders doing with MREO?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on MREO?
Nov 10, 2026: Mereo BioPharma Posts Q3 2026 Financials · Nov 10, 2026: BTIG kept its Buy rating on Mereo BioPharma (MREO). · Nov 9, 2026: Mereo BioPharma Group reports Q3 EPS of $(0.01), sales of $800,000